Dr. An Van Rompay SRL
Dr. An Van Rompay reported total assets of 217,915 € at the end of the 2025 financial year (annual accounts filed with the NBB on 06 Jul 2026).
The score of Dr. An Van Rompay shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity -23 % Total assets -18 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Dr. An Van Rompay's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | −10,430 € | ||||
| Equity | 176,175 € | ||||
| Cash | 41,515 € | ||||
| EBITDA | 7,776 € | ||||
| Total assets | 217,915 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 06 Jul 2026
- Year ended 31 Dec 2024filed on 22 Jul 2025
- Year ended 31 Dec 2023filed on 04 Jun 2024
- Year ended 31 Dec 2022filed on 06 Jun 2023
- Year ended 31 Dec 2021filed on 05 Jul 2022
Dr. An Van Rompay's financial analysis
- Solvency80.8%sector median: 72.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Dr. An Van Rompay
Dr. An Van Rompay's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0896.804.491
- VAT number
- BE0896804491
- Peppol
- Registered · 0208:0896804491 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 31 Mar 2008
- Registered office
- 2970 Schilde
- Latest accounts
- 2025 · filed on 06 Jul 2026
- Activity
- Medical specialists activities (NACE 86220)
Dr. An Van Rompay (SRL) has been based in Schilde since 2008, active in: medical specialists activities. For 2025, it reports a net loss of 10,430 € and equity of 176,175 €; its revenue is not published. Its solvency stands at 80.8%, above the median of its sector (72.2%).
Companies similar to Dr. An Van Rompay
Companies in the same business, of comparable size and area, outside its group.
- Claudia Bevers Oogarts Medical specialists activities Schilde · balance sheet 216,582 €
- Dr. Christophe Korthoudt, Anesthesie Medical specialists activities Schilde · balance sheet 215,937 €
- Chirexpert Medical specialists activities Waterloo · balance sheet 218,441 €
- Docteur Sonja VILLE Medical specialists activities Geer · balance sheet 219,791 €
- Morfei Medical Medical specialists activities Namur · balance sheet 217,984 €
- DR. O. Meeus Medical specialists activities Duffel · balance sheet 218,327 €
- SB Anesthesia Medical specialists activities Liège · balance sheet 217,457 €
- Dr. Carolien Vanholst Oogarts Medical specialists activities Genk · balance sheet 217,272 €
Frequently asked questions about Dr. An Van Rompay
What is the revenue of Dr. An Van Rompay?
Dr. An Van Rompay files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Dr. An Van Rompay?
In Belgium, the VAT number is the company number prefixed with BE: BE0896804491 for Dr. An Van Rompay, if the company is VAT-registered. Its company number (CBE) is 0896.804.491.
Where is the registered office of Dr. An Van Rompay?
According to the CBE register, the registered office of Dr. An Van Rompay is in 2970 Schilde.
What is the equity of Dr. An Van Rompay?
At the close of the 2025 financial year, the equity of Dr. An Van Rompay amounts to 176,175 €, a solvency of 80.8% of total assets.
Who manages Dr. An Van Rompay?
The register lists 1 active mandates at Dr. An Van Rompay. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Dr. An Van Rompay
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →